








 The epithelium plays a crucial role as an interface of adaptive responses and innate responses to prevent 
invasion of inhaled environmental pathogens. This paper summarizes the recent progress in our understanding of 
the regulation of defense mechanisms in the upper airway epithelium under normal and viral-infected conditions. 
Among respiratory viruses, respiratory syncytial virus (RSV) is the major infectious agent that causes serious 
UHVSLUDWRU\WUDFWLQÁDPPDWLRQLQLQIDQWV569XSUHJXODWHVDUHFHSWRUIRUStreptococcus pneumoniae. In our study, 
ZHIRXQGWKDWFODULWKURP\FLQDQGIRVIRP\FLQVLJQLÀFDQWO\VXSSUHVVHG569LQGXFHGDGKHVLRQRIS. pneumonia in the 
airway epithelium. Moreover, these macrolide antibiotics are known to exert immunomodulatory activity by 
UHGXFLQJSURLQÁDPPDWRU\F\WRNLQHDQGLQWHUIHURQSURGXFWLRQ0HDQZKLOHZHIRXQGWKDWELRORJLFDOSURGXFWVVXFK
as curcumin and humulone have protective effects against RSV and prevent the disruption of the epithelial barrier 
by viral infections in human nasal mucosa. Therefore, they are useful for both the prevention and treatment of 
respiratory viral infections.
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